Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Get Alerts CHE Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.6%
Revenue Growth %: +7.6%
Join SI Premium – FREE
CINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) -- Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company’s 2026 annual stockholders’ meeting.
Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2026. The non-binding proposal on Chemed’s executive compensation was not approved.
Dividend Declared
Following the stockholders’ meeting, Chemed’s Board of Directors declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on June 16, 2026, to stockholders of record as of May 28, 2026. This represents the 220th consecutive quarterly dividend paid to stockholders in Chemed’s 55 years as a public company.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care, and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
| CONTACT: | Michael D. Witzeman |
| (513) 762-6714 |
Source: Chemed Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
- Holafly Discount Code TECHREVIEW Unlocks Exclusive Travel eSIM Savings
- XRP News: Ripple Upgrades the Network Again While Pepeto Quietly Builds the Returns XRP Cannot
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share